{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:03:13Z","timestamp":1774123393565,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1378\/chest.06-1426","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T11:27:21Z","timestamp":1171279641000},"page":"466-473","source":"Crossref","is-referenced-by-count":129,"title":["Antibiotics for Bacteremic Pneumonia"],"prefix":"10.1016","volume":"131","author":[{"given":"Mark L.","family":"Metersky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Houck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale W.","family":"Bratzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.06-1426_bib1","first-page":"1","article-title":"National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data.","volume":"158","author":"Kozak","year":"2005","journal-title":"Vital Health Stat 13"},{"key":"10.1378\/chest.06-1426_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia.","volume":"335","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.06-1426_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkg413","article-title":"How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.","volume":"52","author":"Oosterheert","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.06-1426_bib4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1378\/chest.119.5.1420","article-title":"Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997.","volume":"119","author":"Houck","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.06-1426_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.123.5.1503","article-title":"Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.","volume":"123","author":"Brown","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.06-1426_bib6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.159.21.2576","article-title":"Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.","volume":"159","author":"Stahl","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib7","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention.","volume":"163","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.06-1426_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults.","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.06-1426_bib10","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/archinte.165.17.1992","article-title":"Empirical atypical coverage for inpatients with community-acquired pneumonia.","volume":"165","author":"Shefet","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.38334.591586.82","article-title":"Effectiveness of \u03b2 lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.","volume":"330","author":"Mills","year":"2005","journal-title":"BMJ"},{"key":"10.1378\/chest.06-1426_bib12","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978\u20131997.","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"key":"10.1378\/chest.06-1426_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam-based empirical antibiotic regimen is associated in lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.06-1426_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","article-title":"Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.","volume":"51","author":"Lieberman","year":"1996","journal-title":"Thorax"},{"key":"10.1378\/chest.06-1426_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides: an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.06-1426_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2002.14.1.3","article-title":"Immunomodulating activity of quinolones: review.","volume":"14","author":"Reisbeck","year":"2002","journal-title":"J Chemother"},{"key":"10.1378\/chest.06-1426_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.06-1426_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.200309-1248OC","article-title":"Predicting bacteremia in patients with community-acquired pneumonia.","volume":"169","author":"Metersky","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.06-1426_bib19","unstructured":"Healey JF. Statistics: a tool for social research. Belmont, CA: Wadsworth Publishing Company, 1993"},{"key":"10.1378\/chest.06-1426_bib20","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research (vol I): the analysis of case-control studies. Lyon, France:International Agency for Research on Cancer, LARC Scientific Publications, 1980; 16"},{"key":"10.1378\/chest.06-1426_bib21","unstructured":"Hosmer DW, DeLong DM. Applied logistic regression. New York, NY: John Wiley & Sons, 1989"},{"key":"10.1378\/chest.06-1426_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a ROC (ROC) curve.","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1378\/chest.06-1426_bib23","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.163.14.1718","article-title":"Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia.","volume":"163","author":"Feldman","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1155\/2004\/461392","article-title":"Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremicStreptococcus pneumoniaepneumonia in adults.","volume":"11","author":"Weiss","year":"2004","journal-title":"Can Respir J"},{"key":"10.1378\/chest.06-1426_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00063198-200211000-00007","article-title":"Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease.","volume":"8","author":"Nguyen","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"10.1378\/chest.06-1426_bib27","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1378\/chest.06-1426_bib28","first-page":"201","article-title":"Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel.","volume":"6","author":"Moshkowitz","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"10.1378\/chest.06-1426_bib29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archinte.160.9.1294","article-title":"Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.","volume":"160","author":"Vergis","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.06-1426_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0924-8579(01)00472-1","article-title":"Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia.","volume":"19","author":"Lentino","year":"2002","journal-title":"Int J Antimicrob Agents"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215483321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215483321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:21:07Z","timestamp":1547007667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215483321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0012369215483321"],"URL":"https:\/\/doi.org\/10.1378\/chest.06-1426","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1074736.527648","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}